Yonezawa Hamari’s High Potency Drug Substance Manufacture Facility
A dedicated facility to manufacture high potency drug substances is being constructed!!
Yonezawa Hamari has started construction for a dedicated high potency drug substance manufacture facility which will be operation in April 2019. The facility will manage substances with OEL 1 to 10 μg/m3, Category 4 (Pharma Solutions Co., Ltd.’s Classification) and will also manufacture injection grade APIs. The Hamari Group is expanding its manufacture capabilities to cover highly potent drug substances and provide a comprehensive production system.